Crispr Therapeutics AG vs Eos Energy Enterprises Inc — how do they compare? Crispr Therapeutics AG trades at $50.76 (market cap $4.99B), while Eos Energy Enterprises Inc trades at $4.32 (market cap $1.54B). The key difference: Crispr Therapeutics AG is far larger — about 3.2× Eos Energy Enterprises Inc's market cap, and Crispr Therapeutics AG is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals.
| CRSP | EOSE | |
|---|---|---|
Market Cap | $4.99B | $1.54B |
Sector | Health | Energy |
52-Week High | $76.78 | $19.19 |
52-Week Low | $44.34 | $4.29 |
Enterprise Value | $3.33B | $1.78B |
Trailing returns across standard periods
Latest headlines on both assets
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →